» Articles » PMID: 23990168

Importance of Microbial Natural Products and the Need to Revitalize Their Discovery

Overview
Specialty Biotechnology
Date 2013 Aug 31
PMID 23990168
Citations 134
Authors
Affiliations
Soon will be listed here.
Abstract

Microbes are the leading producers of useful natural products. Natural products from microbes and plants make excellent drugs. Significant portions of the microbial genomes are devoted to production of these useful secondary metabolites. A single microbe can make a number of secondary metabolites, as high as 50 compounds. The most useful products include antibiotics, anticancer agents, immunosuppressants, but products for many other applications, e.g., antivirals, anthelmintics, enzyme inhibitors, nutraceuticals, polymers, surfactants, bioherbicides, and vaccines have been commercialized. Unfortunately, due to the decrease in natural product discovery efforts, drug discovery has decreased in the past 20 years. The reasons include excessive costs for clinical trials, too short a window before the products become generics, difficulty in discovery of antibiotics against resistant organisms, and short treatment times by patients for products such as antibiotics. Despite these difficulties, technology to discover new drugs has advanced, e.g., combinatorial chemistry of natural product scaffolds, discoveries in biodiversity, genome mining, and systems biology. Of great help would be government extension of the time before products become generic.

Citing Articles

Microbial secondary metabolites: advancements to accelerate discovery towards application.

Dinglasan J, Otani H, Doering D, Udwary D, Mouncey N Nat Rev Microbiol. 2025; .

PMID: 39824928 DOI: 10.1038/s41579-024-01141-y.


Assessing Normandy Soil Microbial Diversity for Antibacterial Activities Using Traditional Culture and iChip Methods.

Perrier F, Morice J, Gueulle S, Gery A, Riboulet-Bisson E, Garon D Microorganisms. 2025; 12(12.

PMID: 39770625 PMC: 11679952. DOI: 10.3390/microorganisms12122422.


- co-culture: An investigation of bioagents for controlling -induced basal rot in onion.

Abdelrahem M, Abouelela M, Abo-Dahab N, Hassane A AIMS Microbiol. 2024; 10(4):1024-1051.

PMID: 39628715 PMC: 11609423. DOI: 10.3934/microbiol.2024044.


Biotechnological and pharmaceutical potential of twenty-eight novel type strains of from different environments worldwide.

Nouioui I, Boldt J, Zimmermann A, Makitrynskyy R, Potter G, Jando M Curr Res Microb Sci. 2024; 7:100290.

PMID: 39497933 PMC: 11533595. DOI: 10.1016/j.crmicr.2024.100290.


Broad-spectrum antimicrobial activities of a food fermentate of .

Choi D, Alshannaq A, Bok Y, Yu J Microbiol Spectr. 2024; :e0185424.

PMID: 39436123 PMC: 11619415. DOI: 10.1128/spectrum.01854-24.


References
1.
Xie X, Tang Y . Efficient synthesis of simvastatin by use of whole-cell biocatalysis. Appl Environ Microbiol. 2007; 73(7):2054-60. PMC: 1855665. DOI: 10.1128/AEM.02820-06. View

2.
Wang J, Li G, Lu H, Zheng Z, Huang Y, Su W . Taxol from Tubercularia sp. strain TF5, an endophytic fungus of Taxus mairei. FEMS Microbiol Lett. 2000; 193(2):249-53. DOI: 10.1111/j.1574-6968.2000.tb09432.x. View

3.
BIRKINSHAW J, RAISTRICK H, Ross D . Studies in the biochemistry of micro-organisms. 86. The molecular constitution of mycophenolic acid, a metabolic product of Penicillium Brevi-compactum Dierckx. Part III. Further observations on the structural formula for mycophenolic acid. Biochem J. 1952; 50(5):630-4. PMC: 1197721. DOI: 10.1042/bj0500630. View

4.
Yoneyama H, Katsumata R . Antibiotic resistance in bacteria and its future for novel antibiotic development. Biosci Biotechnol Biochem. 2006; 70(5):1060-75. DOI: 10.1271/bbb.70.1060. View

5.
Bender R, Jablonksy M, Shadid M, Romaine I, Dunlap N, Anklin C . Substituents on etoposide that interact with human topoisomerase IIalpha in the binary enzyme-drug complex: contributions to etoposide binding and activity. Biochemistry. 2008; 47(15):4501-9. PMC: 2737519. DOI: 10.1021/bi702019z. View